0.54
price up icon6.68%   0.0338
after-market Dopo l'orario di chiusura: .55 0.01 +1.85%
loading
Precedente Chiudi:
$0.5062
Aprire:
$0.5125
Volume 24 ore:
643.54K
Relative Volume:
1.29
Capitalizzazione di mercato:
$28.83M
Reddito:
-
Utile/perdita netta:
$-151.16M
Rapporto P/E:
-0.1818
EPS:
-2.97
Flusso di cassa netto:
$-130.08M
1 W Prestazione:
+9.76%
1M Prestazione:
+18.66%
6M Prestazione:
-64.36%
1 anno Prestazione:
-91.30%
Intervallo 1D:
Value
$0.5056
$0.54
Intervallo di 1 settimana:
Value
$0.444
$0.54
Portata 52W:
Value
$0.404
$6.44

Alx Oncology Holdings Inc Stock (ALXO) Company Profile

Name
Nome
Alx Oncology Holdings Inc
Name
Telefono
650-466-7125
Name
Indirizzo
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Name
Dipendente
65
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
ALXO's Discussions on Twitter

Confronta ALXO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ALXO
Alx Oncology Holdings Inc
0.54 25.65M 0 -151.16M -130.08M -2.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-06 Aggiornamento Jefferies Hold → Buy
2024-12-19 Downgrade Jefferies Buy → Hold
2024-03-08 Downgrade Stifel Buy → Hold
2023-12-08 Aggiornamento Jefferies Hold → Buy
2021-12-22 Downgrade Jefferies Buy → Hold
2021-09-30 Iniziato Stifel Buy
2021-05-05 Ripresa Credit Suisse Outperform
2021-04-26 Ripresa Credit Suisse Outperform
2021-04-06 Iniziato UBS Buy
2021-02-10 Iniziato H.C. Wainwright Buy
2020-08-11 Iniziato Cantor Fitzgerald Overweight
2020-08-11 Iniziato Credit Suisse Outperform
2020-08-11 Iniziato Jefferies Buy
2020-08-11 Iniziato Piper Sandler Overweight
Mostra tutto

Alx Oncology Holdings Inc Borsa (ALXO) Ultime notizie

pulisher
Jul 24, 2025

What analysts say about ALX Oncology Holdings Inc. stockTriple returns potential - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

ALX Oncology Holdings Inc. Stock Analysis and ForecastPhenomenal returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Is ALX Oncology Holdings Inc. stock overhyped or has real potentialAccelerated financial growth - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives ALX Oncology Holdings Inc. stock priceOverwhelming profit margins - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is ALX Oncology Holdings Inc. a good long term investmentMarket-beating returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 18, 2025

Will ALX Oncology Holdings Inc. stock benefit from interest rate changesConsistent Win Signals - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

How ALX Oncology Holdings Inc. stock performs during market volatilitySwing Trade Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes ALX Oncology Holdings Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why ALX Oncology Holdings Inc. stock attracts strong analyst attentionPredictable High Return Trades - Newser

Jul 15, 2025
pulisher
Jul 08, 2025

ALX Oncology (NASDAQ:ALXO) Trading Down 3.5% – What’s Next? - Defense World

Jul 08, 2025
pulisher
Jun 16, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Jun 16, 2025
pulisher
Jun 12, 2025

ALX Oncology Confirms Directors at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

ALX Oncology reports annual meeting results By Investing.com - Investing.com Nigeria

Jun 12, 2025
pulisher
Jun 12, 2025

ALX Oncology reports annual meeting results - Investing.com

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Weighs in on ALX Oncology FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 07, 2025

ALX Oncology (NASDAQ:ALXO) Downgraded to “Sell” Rating by Wall Street Zen - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Has $275,000 Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Two Sigma Investments LP - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Bank of America Corp DE Grows Position in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Deutsche Bank AG - Defense World

Jun 03, 2025
pulisher
May 31, 2025

Northern Trust Corp Acquires 23,324 Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

May 31, 2025
pulisher
May 30, 2025

ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference | ALXO Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

ALX Oncology Management to Showcase Novel Cancer Treatment Advances at Major Jefferies Healthcare Conference - Stock Titan

May 30, 2025
pulisher
May 27, 2025

D. E. Shaw & Co. Inc. Decreases Stock Position in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

May 27, 2025
pulisher
May 27, 2025

H.C. Wainwright maintains ALX Oncology stock Buy rating By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

H.C. Wainwright maintains ALX Oncology stock Buy rating - Investing.com

May 27, 2025
pulisher
May 24, 2025

Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and ALX Oncology Holdings (ALXO) - The Globe and Mail

May 24, 2025

Alx Oncology Holdings Inc Azioni (ALXO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):